13. Baumgartner, H. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography / H. Baumgartner, J. Hung, J. Bermejo et al. // Eur Heart J Cardiovasc Imaging. – 2017. – V. 18. – № 3. – V. 254–275.
14. Baumgartner, H. 2017 ESC/EACTS Guidelines for the management of valvular heart disease / Baumgartner H., Falk V, Bax J., et al. / Eur Heart J. – 2017. – V. 36. – № 38. – P. 2739–2791.
15. Blanco, A. C. Functional recovery of the cardio-respiratory patient / A. C. Blanco // Nutr Hosp. – 2019. – V. 36. – № 2. – P. 38–43.
16. Bonow, R. O. On behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 5: Valvular heart disease: a scientific statement from the American Heart Association and American College of Cardiology / R. O. Bonow, R. A. Nishimura, P. D. Thompson, J. E. Udelson // J Am Coll Cardiol. – 2015. – № 66. – P. 2385–2392.
17. Borjesson, M. Recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease: a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC) / M. Borjesson, M. Dellborg, J. Niebauer, A. LaGerche et al. // Eur Heart J. – 2019. – V. 40. – № 1. – P. 13–18.
18. Braverman, A. C. On behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 7: aortic diseases, including Marfan syndrome: a scientific statement from the American Heart Association and American College of Cardiology / A. C. Braverman, K. M. Harris, R. J. Kovacs, B. J. Maron // J Am Coll Cardiol. – 2015. – № 66. – P. 2398–405.
19. Budts, W. Practice Guideline Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease (CHD): position statement of the Sports Cardiology & Exercise Section of the European Association of Preventive Cardiology (EAPC), the European Society of Cardiology (ESC) Working Group on Adult Congenital Heart Disease and the Sports Cardiology, Physical Activity and Prevention Working Group of the Association for European Paediatric and Congenital Cardiology (AEPC) / W. Budts, G. Pieles, J. Roos-Hesselink et al. // Eur Heart J. – 2020. – V. 41. – № 43. – P. 4191–4199.
20. Carbone, A. Mitral Prolapse: An Old Mysterious Entity – The Incremental Role of Multimodality Imaging in Sports Eligibility / A. Carbone, A. D'Andrea, G. Scognamiglio et al. // P. J Cardiovasc Echogr. – 2018. – V. 28. – № 4. – P. 207–217.
21. Chaix, M. A. Risks and Benefits of Exercise Training in Adults With Congenital Heart Disease / M. A. Chaix, F. Marcotte, A. Dore et al. // J Cardiol. – 2016. – V. 32. – № 4. – P. 459–66.
22. Christensen, N. L. Association Between Left Atrial Dilatation and Invasive Hemodynamics at Rest and During Exercise in Asymptomatic Aortic Stenosis / N. L. Christensen, J. S. Dahl, R. Carter-Storch et al. // Circ Cardiovasc Imaging. – 2016. – Oct; 9(10): e005156.
23. Cipriani, A. Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance / A. Cipriani, A. Zorzi, P. Sarto et al. // Heart Rhythm. – 2019. – V. 16. – № 2. – P. 239–248.
24. Corrado, D. How to evaluate premature ventricular beats in the athlete: critical review and proposal of a diagnostic algorithm / D. Corrado, J. A. Drezner, F. D'Ascenzi, A. Zorzi // Br J Sports Med. – 2020. – V. 19. – № 54. – P. 1142–1148.
25. Czimbalmos, C. The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart / C. Czimbalmos, I. Csecs, A. Toth et al. // PLoS One. – 2019. – Feb 14; 14(2): e0211624.
26. Dahash, B. A. Carnitine Deficiency / B. A. Dahash, S. Sankararaman. – 2021. – In: StatPearls [Internet].
27. D'Ascenzi, F. The prevalence and clinical significance of premature ventricular beats in the athlete / F. D'Ascenzi, A. Zorzi, F. Alvino// Scand J Med Sci Sports. – 2017. – V. 27. – № 2. – P. 140–151.
28. De Noronha, S. V. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study / S. V. De Noronha, S. Sharma, M. Papadakis et al. // Heart. – 2009. – № 95. – P. 1409–14.
29. Dean Peter, N. Congenital Heart Disease and the Athlete: What We Know and What We Do Not Know / N. Peter Dean, W. Robert // Cardiology Clinics. – 2016. – V. 34. – № 4. – P. 579–589.
30. Elliott, A. D. Atrial remodeling and ectopic burden in recreational athletes: Implications for risk of atrial fibrillation / A. D. Elliott, R. Mahajan, D. Linz et al. // Clin Cardiol. – 2018. – V. 41. – № 6. – P. 843–848.
31. Elliott, A. D. Exercise and Atrial Fibrillation: Prevention or Causation? / A. D. Elliott, D. Linz, C. V. Verdicchio, P. Sanders // Heart Lung Circ. – 2018. – V. 27. – № 9. – P. 1078–1085.
32. Farzam, K. QT Prolonging Drugs / K. Farzam, V. S. Tivakaran // Treasure Island (FL): StatPearls Publishing. – 2021.
33. Farzam, K. Sports Participation Evaluation In: StatPearls / K. Farzam, H. Akhondi // Treasure Island (FL): StatPearls Publishing. – 2020.
34. Finocchiaro, G. Etiology of sudden death in sports: insights from a United Kingdom regional registry / G. Finocchiaro, M. Papadakis, J. L. Robertus, et al. // J Am Coll Cardiol. – 2016. – V. 67. – P. 2108–2115.
35. Gomez, A. T. Evaluation and Management of Athletes With Long QT Syndrome / A. T. Gomez, J. M. Prutkin, A. L. Rao et al. // Sports Health. – 2016. – V. 8. – № 6. – P. 527–535.
36. Harmon, K. G. Incidence, etiology, and comparative frequency of sudden cardiac death in NCAA Athletes: a decade in review / K. G. Harmon, I. M. Asif, J. J. Maleszewski, et al. // Circulation. – 2015. – № 132. – P. 10–19.
37. Harmon, K. G. Review Incidence of sudden cardiac death in athletes: a state-of-the-art review / K. G. Harmon, J. A. Drezner, M. G. Wilson, S. Sharma // Br J Sports Med. – 2014. – V. 48. – № 15. – P. 1185–92.
38. Harmon, K. G. The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/meta-analysis / K. G. Harmon, M. Zigman, J. A. Drezner // J Electrocardiol. – 2015. – V. 48. – № 3. – P. 329–338.
